MUC Research GmbH
About MUC Research GmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
7
Clinical Trials at MUC Research GmbH
During the past decade, MUC Research GmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
2010-04-01
2014-09-01
Completed
708
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
2011-02-01
2014-02-01
Completed
799
Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients
2011-12-01
2014-12-01
Completed
439
Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants
2013-03-27
2020-04-01
Completed
1,443
A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects
2013-02-01
2014-10-01
Completed
476
Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults
2015-01-26
2019-01-02
Completed
881
Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF)
2015-01-26
2019-01-09
Completed
632
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at MUC Research GmbH
According to Clinical.Site data, the most researched conditions in "MUC Research GmbH" are
"HIV Infections" (4 trials), "HIV-1 Infection" (3 trials), "HIV" (2 trials) and "Acquired Immunodeficiency Syndrome" (1 trials). Many other conditions were trialed in "MUC Research GmbH" in a lesser frequency.
Clinical Trials Intervention Types at MUC Research GmbH
Most popular intervention types in "MUC Research GmbH" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "EFV/FTC/TDF" (3 trials), "FTC/TDF" (3 trials), "ATV" (2 trials), "FTC/RPV/TAF" (2 trials) and "FTC/RPV/TAF Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at MUC Research GmbH
The vast majority of trials in "MUC Research GmbH" are
7 trials for "All" genders.
Clinical Trials Status at MUC Research GmbH
Currently, there are NaN active trials in "MUC Research GmbH".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in MUC Research GmbH,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MUC Research GmbH, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".